Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation

Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation

Bibliographic Details
Main Authors:	Girish Gilly Munavalli, MD, MHS, FACMS, Siri Knutsen-Larson, MD, Mary P. Lupo, MD, Roy G. Geronemus, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	JAAD Case Reports
Subjects:	angiotensin-converting enzyme inhibitor angiotensin II COVID-19 delayed inflammatory reaction (DIR) dermal filler delayed inflammatory reaction
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512621001375

Similar Items

TO90 inhibits angiotensin II-induced inflammatory response by up-regulating ACE2/Ang-(1-7)/MAS receptor axis in human retinal pigment epithelial cells
by: MAI Yuxin, et al.
Published: (2019-10-01)

Delayed sclerosing granulomatous reaction to dermal filler injection of poly‐hydroxyethyl‐methacrylate suspended in hyaluronic acid: Histochemical and confocal laser scanning microscopical analysis
by: Saverio Capodiferro, et al.
Published: (2019-11-01)

The Immunogenicity of Hyaluronic Fillers and Its Consequences
by: Owczarczyk-Saczonek A, et al.
Published: (2021-07-01)

Management Patterns of Delayed Inflammatory Reactions to Hyaluronic Acid Dermal Fillers: An Online Survey in Israel
by: Shalmon D, et al.
Published: (2020-05-01)

Effects of DA-9801 on the inflammation and apoptosis induced by angiotensin II in human dermal microvascular endothelial cells
by: Oak-Kee Hong, et al.
Published: (2021-01-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

A case of cellulitis-like foreign body reaction after hyaluronic acid dermal filler injection
by: Yo Sup Shin, et al.
Published: (2018-03-01)

A Comprehensive Literature Review of Non-‐cough Adverse Drug Reactions (ADRs) Associated With Angiotensin
by: Monaco, Dominick, et al.
Published: (2010)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

Antihypertensive effects of angiotensin-(1-7)
by: M.C. Chappell, et al.
Published: (1998-09-01)

Angiotensin-(1–7) attenuates organ injury and mortality in rats with polymicrobial sepsis
by: Hsin-Jung Tsai, et al.
Published: (2018-10-01)

Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
by: Dejan Marčetić, et al.
Published: (2021-07-01)

Angiotensin II and Angiotensin Receptors 1 and 2—Multifunctional System in Cells Biology, What Do We Know?
by: Maksymilian Ziaja, et al.
Published: (2021-02-01)

The renin-angiotensin system and its blockers
by: Igić Rajko, et al.
Published: (2014-01-01)

Editorial: The Role of the Renin-Angiotensin System in the Central Nervous System
by: Natalia P. Rocha, et al.
Published: (2021-07-01)

Renal actions of angiotensin-(1-7)
by: A.C. Simões-e-Silva, et al.
Published: (1997-04-01)

Advances in angiotensin-(1-7) and atrial fibrillation
by: Yan-Guang Miao, et al.
Published: (2019-06-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors
by: Janković Slobodan M., et al.
Published: (2011-01-01)

ADAMTS-7 Expression Increases in the Early Stage of Angiotensin II-Induced Renal Injury in Elderly Mice
by: Yan-Xiang Gao, et al.
Published: (2014-03-01)

Angiotensin 1-7 receptor and angiotensin ii receptor 2 blockades prevent the increased serum and kidney nitric oxide levels in response to angiotensin ii administration: Gender-related difference
by: Tahereh Safari, et al.
Published: (2013-01-01)

The clinical relevance of local renin angiotensin systems
by: Duncan John Campbell
Published: (2014-07-01)

Role of Angiotensin Type 2 Receptor on Nitric Oxide Production Response to Angiotensin II Administration in Ovariectomised Rats Treated with Estradiol
by: Tahereh Safari, et al.
Published: (2014-01-01)

Plasma and tissue angiotensin‐converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease
by: Éva Larouche‐Lebel, et al.
Published: (2019-07-01)

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
by: Rinaldo Bellomo, et al.
Published: (2020-02-01)

Increased angiotensin-converting enzyme activity in the left ventricle after infarction
by: V.C.W. Busatto, et al.
Published: (1997-05-01)

Advance in Research of Angiotensin II and Its Receptor and Malignant Tumor
by: Lulu SUN, et al.
Published: (2016-09-01)

Studies on angiotensin II receptors
by: Cox, H. M.
Published: (1982)

Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?
by: Bilgehan Karadağ
Published: (2020-07-01)

The role of the angiotensins in the pathogenesis of inflammatory joint disease
by: Andrei V. Gordeev, et al.
Published: (2021-05-01)

Alternative pathways for angiotensin II generation in the cardiovascular system
by: C. Becari, et al.
Published: (2011-09-01)

Alternative pathways for angiotensin II generation in the cardiovascular system
by: C. Becari, et al.
Published: (2011-09-01)

Einfluss des Angiotensin-II-Rezeptorantagonisten Valsartan auf die chronische Nierentransplantat-Insuffizienz der Ratte
by: Brookman-Amissah, Dominic
Published: (2007)

Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients
by: Wenjun Wang, et al.
Published: (2021-01-01)

Renin-angiotensin system: role in the development and progression of prostate cancer
by: E. A. Chernogubova, et al.
Published: (2021-02-01)

A persistent dermal hypersensitivity reaction associated with Helicobacter pylori infection
by: Cula N. Dautriche, MD, PhD, et al.
Published: (2020-02-01)

Perspectives of using angiotensin receptor antagonists
by: V V Fomin
Published: (2009-06-01)

Pathological Role of Angiotensin II in Severe COVID-19
by: Wolfgang Miesbach
Published: (2020-04-01)

Role of Nonclassical Renin-angiotensin system Axis In Renal Fibrosis
by: Linli eLv, et al.
Published: (2015-04-01)